期刊
CANCER LETTERS
卷 470, 期 -, 页码 197-203出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2019.11.029
关键词
Liver cancer; Mitochondria; Immune checkpoint; Therapeutic target
类别
资金
- National Natural Science Foundation of China [81400659, 81974377]
- Natural Science Fund of Liaoning Province [2017225032, 20180551193]
- Shenyang Science and Technology Project [17-230-9-16]
Mitochondria are known as essential biosynthetic, bioenergetic and signaling organelles, and play a critical role in cell differentiation, proliferation, and death. Nowadays, cancer is emergingly considered as a mitochondrial metabolic disease. Mitochondria also play an essential role in liver carcinogenesis. Liver cells are highly regenerative and require high energy. For that reason, a large number of mitochondria are present and functional in liver cells. Abnormalities in mitochondrial metabolism in human liver are known to be one of the carcinogenic factors. Interestingly, immune checkpoints regulate mitochondrial metabolic energetics of the tumor, the tumor microenvironment, as well as the tumor-specific immune response. This regulation forms a positive loop between the metabolic reprogramming of both cancer cells and immune cells. In this review, we discuss the evidence and mechanisms that mitochondria interplay with immune checkpoints to influence different steps of oncogenesis, as well as the potential of mitochondria as therapeutic targets for liver cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据